Viewing Study NCT01485835


Ignite Creation Date: 2025-12-24 @ 10:40 PM
Ignite Modification Date: 2026-02-22 @ 4:53 PM
Study NCT ID: NCT01485835
Status: COMPLETED
Last Update Posted: 2015-10-12
First Post: 2011-12-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
Sponsor: Emory University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module